Clinical Trials

Phase 2 Active not recruiting

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT03891784 2026-01-14

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

20 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell

NCT02159989 2025-10-20

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

GastrointestinalGynecologic

83 enrolled 21 charts

Fibrolamellar hepatocellular carcinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Ovarian Neoplasms

NCT07165132 2025-09-10

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Phase 1 Not yet recruiting

104 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06024343 2024-11-07

Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction

Phase NA Completed

230 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT05610826 2024-10-26

Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver

Phase 1/2 Withdrawn

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT05997056 2024-07-16

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Phase 2 Recruiting

21 enrolled

Phase NA Not yet recruiting

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06167421 2023-12-12

Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy

240 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

139 enrolled

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

NCT05800106 2023-04-10

A Bioequivalence Study of Sunitinib Malate Capsules.

GastrointestinalGenitourinarySarcoma

24 enrolled

Carcinoma, Renal Cell, Adenoma, Islet Cell, Gastrointestinal Stromal Tumors

NCT03147768 2022-04-06

LTW

EndocrineGastrointestinal

11 enrolled

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms, Pancreatic Pseudocyst

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Phase NA Completed

223 enrolled 8 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT03435770 2018-02-20

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

Phase NA Unknown

10 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT03417843 2018-02-13

yes

Phase NA Unknown

20 enrolled

Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms

NCT01563133 2017-08-29

CONTACT

Phase NA Unknown

330 enrolled

Pancreatic adenoma, Lymphadenopathy, Cysts, Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms, Arachnodactyly

NCT02759718 2016-05-03

CgA

Phase 4 Unknown

111 enrolled

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell

NCT01215578 2015-04-30

NET

Phase 2 Terminated

33 enrolled

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT00671463 2013-06-11

LEAPS

Phase NA Withdrawn